HomeALNEV • EPA
add
Neovacs SA
Previous close
€0.0068
Day range
€0.0058 - €0.0070
Year range
€0.0058 - €4,150.00
Market cap
9.57K EUR
Avg Volume
9.54M
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 60.30K | -72.02% |
Operating expense | 769.22K | -7.29% |
Net income | -961.71K | 56.88% |
Net profit margin | -1.59K | -54.12% |
Earnings per share | — | — |
EBITDA | 1.89M | 254.10% |
Effective tax rate | 23.25% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 435.44K | -50.91% |
Total assets | 22.07M | -58.01% |
Total liabilities | 4.01M | 7.82% |
Total equity | 18.06M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -17.31% | — |
Return on capital | -20.88% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -961.71K | 56.88% |
Cash from operations | -330.60K | -144.85% |
Cash from investing | -132.08K | 96.80% |
Cash from financing | 564.61K | -23.76% |
Net change in cash | 101.92K | 103.84% |
Free cash flow | 2.27M | 424.12% |
About
Founded
1993
Website
Employees
20